Annex A
Status of
Ref. Observation Recommendation Implementation/Results
of Validation
9, page of drugs and and Awards Confirmation of
35 medicines amounting Committee (BAC) procurement transactions
to ₱1,659,000.00 Chairman, cannot be achieved since
even though each of henceforth, use the disbursement vouchers
their unit costs latest DPRI as the relating thereto were not
exceeded the Drug ceiling price in the submitted.
Price Reference procurement of drugs
Index (DPRI) and medicines in
provided by the compliance with RA
DOH, contrary to RA No. 9502 and DOH
No. 9502 and DOH AO No. 2019-0040
AO No. 2019-0040 dated October 14,
dated October 14, 2019.
2019, hence, not
securing the best
value for money in
procuring essential
pharmaceutical
products.
AAR Complete detailed 18. The BAC ensure the Unimplemented
2023, specifications, such indication of
AO no. as the pharmaceutical complete detailed Confirmation of
10, page form and strength, specifications in the procurement transactions
37 were not indicated in PO before cannot be achieved since
the Purchase Orders proceeding with the disbursement vouchers
and (POs) in the delivery of drugs and relating thereto were not
procurement of drugs medicines. submitted.
AAR and medicines
2022, totaling
AO no. ₱1,624,536.00,
5, page inconsistent with
32 Item B of COA
Circular No. 96-010
dated August 15,
1996, thus, potency
and safety, as well as
the reasonableness of
prices of these drugs
and medicines, could
not be guaranteed.
